
	Home \| Wikikidney \| Dialysis Units \| CKD \| Physicians \| RNS & Administrators \| Nutrition \| \| KIDNEYDISEASE \| Disasters \| Patient Education \| Find Unit by Address \| Issues \| MDRD GFR \| AAKP \| K DOQI \| Epocrates \| UpToDate \| HDCN \| Bills \| Translate

TEXT SEARCH

STRUCTURED SEARCHES

for:

Citematch Search by Citation - Hubmed works with EndNote and newsreaders

Epocrates on iPhone | TouchCalc on iPhone

Sarcoma Key Sites

Clinical Trials

Sockeye Steve fishing for salmon in Alaska*

Sarcoma News and Recent Articles

Renal toxicity following zoledronic acid reversed with ibandronate in a prostate cancer patient with bone metastases.
Vitamin D and the immune system: role in protection against bacterial infection.
The noncalciotropic actions of vitamin D: recent clinical developments.
Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.
Oral active vitamin D is associated with improved survival in hemodialysis patients.
Survival Impact of Vitamin D Therapy in Hemodialysis Patients
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
Primary angiosarcoma arising from a multicystic kidney.
Association between the Medicare modernization act of 2003 and patient wait times and travel distance for chemotherapy.
Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.
Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor-Mediated Sequestration of NF-{kappa}B Signaling.
Iron indices and vitamin D receptor polymorphisms in hemodialysis patients.
High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
Ipsilateral Synchronous Neoplasms of Kidney Presenting as Acute Pyelonephritis and Bladder Metastasis.
Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair.
Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib.
Vitamin D: an old prohormone with an emergent role in chronic kidney disease.
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease.
Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney.
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.
Vitamin D compounds in chronic kidney disease.
Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol.
Vitamin D Compounds in Chronic Kidney Disease
The role of chemotherapy at the end of life: "when is enough, enough?".
New surgical horizons: the role of cytoreductive nephrectomy for metastatic kidney cancer.
Falecalcitriol for conventional vitamin D therapy-resistant secondary hyperparathyroidism in a continuous ambulatory peritoneal dialysis patient.
Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study.
Hypertension and Rarefaction during Treatment with Telatinib, a Small Molecule Angiogenesis Inhibitor.
In Vitro and In Vivo Investigation on PLA-TPGS Nanoparticles for Controlled and Sustained Small Molecule Chemotherapy.
Improved patient outcomes in chronic kidney disease: optimizing vitamin D therapy.
Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response.
Surgical treatment of a rare primary renal carcinoid tumor with liver metastasis.
A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.
[Determining S-1 dosage at hospitals prioritizing cancer chemotherapy]
Adenoid cystic carcinoma metastatic to the kidney: a case report.
Primary synovial sarcoma of the kidney.
Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis.
Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody.
Vitamin D receptor defects: the story of hereditary resistance to vitamin D.
[Bilateral adrenal metastases from renal cell carcinoma: a case report]
[Primary synovial sarcoma of the kidney]
A case of recurrent invasive lobular carcinoma of the breast found as metastasis to the duodenum.

About the author
e-mail the author

*The medical literature suggests that omega-3 fatty acids may interfere with sarcoma growth, with lipid metabolism and the progression of IgA nephropathy. In addition, salmon fishing is fun, and they are good to eat. I cannot think of a more delicious way to keep healthy

We comply with the HONcode standard for health trust worthy information:
verify here

About The Nephron Information Center | Contact the webmaster: fadem@nephron.com

© 2004-7 Nephron Information Center. All Rights Reserved. No part of this page can be reproduced without permission of the author. | Page coding updated April 21 2005. Content last updated dynamically at Last updated Thu, 07 Aug 2008 04:14:24 -0500. .